Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Hetrombopag Olamine Tablets Vs Placebo in Patients With Chemotherapy-Induced Thrombocytopenia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial to evaluate the efficacy and safety of hetrombopag olamine tablets versus placebo in patients with chemotherapy-induced thrombocytopenia;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Thrombocytopenia

Drugs mentioned

• Hetrombopag Olamine Tablets (hetrombopag olamine)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Patients With Chemotherapy-Induced Thrombocytopenia | Phase 3 | Status: NOT_YET_RECRUITING